« Previous Entries Next Entries »

Physical activity in COPD patients reduces re-hospitalization risk

Tuesday, April 15th, 2014

Chronic obstructive pulmonary disease (COPD) patients are often quite sedentary, but new research indicates that some physical exercise may help reduce the risk of their re-hospitalization. More specifically, the research shows that people admitted in a hospital for COPD were less likely to be admitted again within 30 days of leaving if they stayed more […]

More Beta-blockers need to be prescribed to fight COPD

Tuesday, January 7th, 2014

A UK-based research team has said that the low use of beta-blockers may be contributing to higher mortality rates among patients with chronic obstructive pulmonary disease (COPD). The team includes Jennifer Quint and colleagues from the London School of Hygiene and Tropical Medicine, UK. The researchers conducted a study and found that COPD patients on […]

Wealth is a Stronger Factor for COPD Mortality than Smoking Prevalence

Friday, January 3rd, 2014

A recent international study suggests that national mortality rates of chronic obstructive pulmonary disease (COPD) show a strong correlation with wealth but a weak one with smoking prevalence. This surprising result was observed in low-income countries. The study was done by Peter Burney and colleagues from the Imperial College, London, UK. The study results show […]

COPD Patients More Likely to Be Hospitalized for Pneumonia

Thursday, December 5th, 2013

According to a recent US-based study, older patients diagnosed with chronic obstructive pulmonary disease (COPD) have a six-fold greater risk of pneumonia. They also have an eight-fold greater risk of hospitalization due to the disease than non-COPD patients. The study was done by Marian Ryan and colleagues from the Brandeis University, Waltham, Massachusetts. According to […]

Community Pharmacy Intervention helps COPD Treatment Adherence

Tuesday, December 3rd, 2013

A recently-published randomized trial study showed that community pharmacist-based intervention helped chronic obstructive pulmonary disease (COPD) patients improve their treatment adherence. More specifically, it helped improve their medication adherence and inhalation technique. The study was led by Eline Tommelein from the Ghent University, Belgium, and colleagues. The Pharmaceutical Care for COPD (PHARMACOP) study also suggested […]

New Data Reveals Dip in COPD Prevalence

Monday, May 6th, 2013

The occurrence of Chronic Obstructive Pulmonary Disease or COPD, adjusted for age, has significantly reduced in the last decade in the U.S., according to new national data. This data also shows a decline in mortality and hospitalization rates among COPD patients during the decade from 1999 to 2010. This new data seems to indicate the […]

Levels of fatigue determine hospitalization in COPD patients

Monday, June 25th, 2012

A new study found that the level of fatigue and energy levels in the patient will help in determining the risk of hospitalization in chronic obstructive pulmonary disease (COPD). The study was conducted by a group of researchers headed by Dr. Johanna Susan Paddison from the Repatriation General Hospital in Adelaide, Australia. The results of […]

Cured meat consumption increases risk of COPD

Sunday, March 18th, 2012

People who suffer from chronic obstructive pulmonary disease (COPD) are at a high risk of hospitalization if they eat excess amount of cured meat such as chorizo, salami and bacon, says a new study. The study was conducted by Judith Garcia-Aymerich and her colleagues from the Centre for Research in Environmental Epidemiology, Barcelona, Spain. The […]

Adherence to action plan reduces COPD exacerbation recovery time

Thursday, January 13th, 2011

Source: MedWire News Patients with chronic obstructive pulmonary disease (COPD) can minimize their recovery time after an exacerbation by sticking to a written action plan, research shows. Writing in the journal Thorax, Jean Bourbeau (McGill University Health Centre, Montréal, Canada) and team explain: “Despite the huge impact [COPD] exacerbations may have, patients often have problems in […]

Long-term LABA treatment does not increase CV events in COPD

Monday, August 16th, 2010

Source: MedWire News Long-term treatment with long-acting β2-agonists (LABAs) does not increase the risk for cardiovascular (CV) events in patients with chronic obstructive pulmonary disease (COPD), research suggests. Writing the journal Thorax, Peter Calverley (University Hospital Aintree, UK) and colleagues explain: “Recently there has been concern that the long-term use of inhaled bronchodilators commonly used in […]

« Previous Entries Next Entries »